Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Peritoneal Neoplasms 3Colorectal Neoplasms 3Appendiceal Neoplasms 3Anus Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Ovarian Neoplasms 2Liver Neoplasms 2Carcinoma, Hepatocellular 2Uterine Neoplasms 1Urothelial Carcinoma Ureter 1Unspecified Adult Solid Tumor, Protocol Specific 1Solid Neoplasm 1Peritoneal Diseases 1Pancreatic Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasm Metastasis 1Necrosis 1Lung Metastases 1Leukemia, Myeloid, Acute 1Leukemia 1Gastrointestinal Neoplasms 1Dermatitis 1

Interventions

Sorafenib 20Bevacizumab 7pembrolizumab 5Oxaliplatin 5Melphalan 5Leucovorin 5Irinotecan 5Nivolumab 4Ipilimumab 4Fluorouracil 4Cyclophosphamide 4Capecitabine 4fludarabine 3Sirolimus 3Radiosurgery 3Gemcitabine 3Filgrastim 3Carboplatin 3toripalimab 2spartalizumab 2regorafenib 2pazopanib 2lenvatinib 2ixabepilone 2durvalumab 2atezolizumab 2Vorinostat 2Thiotepa 2Temozolomide 2Sirtuins 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Liver Neoplasms × Mitomycin × Clear all
NCT01011010 2018-01-05

Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

UNC Lineberger Comprehensive Cancer Center

Phase 1 Completed
11 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01042041 2013-02-26

Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer

Abramson Cancer Center at Penn Medicine

Phase 1 Completed
18 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡